Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
J0300782 | 肿瘤坏死因子α单克隆抗体注射剂 | adalimumab | Injection | Biological Products(7) | Import Drug Application | 2004-06-09 | Abbott Laboratories Ltd | Abbott Laboratories Ltd | Certificate Issued | 2004-12-27 | view |
JXSL0800012 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2008-06-25 | Abbott Laboratories Ltd. | Abbott Laboratories Ltd | Certificate Issued | 2009-06-04 | view |
JXSS0900001 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2009-02-06 | Abbott Laboratories Ltd. | Abbott Laboratories Ltd | Certificate Issued | 2010-03-12 | view |
JXSL0900007 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2009-03-26 | Abbott Laboratories Ltd. | Abbott Laboratories Ltd | Certificate Issued | 2010-11-23 | view |
JXHL1000203 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | Import Drug Application | 2010-07-22 | Abbott laboratories Ltd | Abbott Laboratories Ltd | Certificate Issued | 2011-07-28 | view |
JXSL1100026 | 注射用帕利珠单抗 | palivizumab | Lyophilized | Biological Products | Import Drug Application | 2011-06-28 | Abbott Laboratories Ltd. | Abbott Laboratories Ltd | Certificate Issued | 2013-02-18 | view |
JXSL1100025 | 注射用帕利珠单抗 | palivizumab | Lyophilized | Biological Products | Import Drug Application | 2011-07-19 | Abbott Laboratories Ltd. | Abbott Laboratories Ltd | Certificate Issued | 2015-09-08 | view |
JXSS1100004 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2011-09-29 | Abbott Laboratories Ltd. | Abbott Laboratories Ltd | Certificate Issued | 2013-04-11 | view |
JYHB1101208 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2011-12-22 | Abbott Laboratories Ltd | Abbott Laboratories Ltd | Certificate Issued | 2012-07-20 | view |